These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17898104)

  • 1. Will MICA glitter for recipients of kidney transplants?
    Flegel WA
    N Engl J Med; 2007 Sep; 357(13):1337-9. PubMed ID: 17898104
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies against MICA antigens and kidney-transplant rejection.
    Zou Y; Stastny P; Süsal C; Döhler B; Opelz G
    N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is it time to prospectively match human leukocyte antigen proteins for lung transplantation?
    Neuringer IP; Aris RM
    Transplantation; 2010 Oct; 90(8):823-4. PubMed ID: 20697323
    [No Abstract]   [Full Text] [Related]  

  • 4. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
    Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
    Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of MICA antigens on kidney transplantation outcomes.
    Luo L; Li Z; Wu W; Luo G; Mei H; Sun Z; Xu C
    Immunol Lett; 2013; 156(1-2):54-8. PubMed ID: 24004718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
    Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF
    Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MICA compatibility and immunization in third kidney transplantations.
    Gautier AC; Devys A; Cheneau ML; Simon PH; Martin C; Allard S; Hourmant M; Bignon JD
    Transplant Proc; 2009 Mar; 41(2):663-5. PubMed ID: 19328950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major histocompatibility complex class 1 chain-related antigen a antibodies: sensitizing events and impact on renal graft outcomes.
    Lemy A; Andrien M; Wissing KM; Ryhahi K; Vandersarren A; Racapé J; Heylen C; Ghisdal L; Broeders E; Vereerstraeten P; Toungouz M; Abramowicz D
    Transplantation; 2010 Jul; 90(2):168-74. PubMed ID: 20463636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement for DR sharing in stable kidney allograft tolerance induced by donor bone marrow in rhesus monkeys.
    Thomas J; Kasten-Jolly J; Verbanac K; Smith JP; Carver M; Gross U; Rebellato L; Thomas F; Haisch C
    Transplant Proc; 1995 Feb; 27(1):686-8. PubMed ID: 7879146
    [No Abstract]   [Full Text] [Related]  

  • 11. Relevance of positive crossmatches in renal transplantation.
    Horsburgh T; Mistry N; Weston S; Morgan J; Donnelly PK; Veitch PS; Bell PR
    Transplant Proc; 1992 Dec; 24(6):2508-9. PubMed ID: 1465848
    [No Abstract]   [Full Text] [Related]  

  • 12. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
    Süsal C; Opelz G
    Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term success rate of HLA-DRB1 compatible kidney transplants.
    Nojima M; Ichikawa Y; Ihara H; Ishibashi M; Ohshima S; Ikoma F
    Transplant Proc; 1993 Dec; 25(6):3056-9. PubMed ID: 8266451
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of tolerance to allogeneic major histocompatibility complex antigens on rejection across minor antigen differences.
    Smith CV; Fishbein J; Nakajima K; Rosengard BR; Guzzetta PC; Sachs DH
    Transplant Proc; 1993 Feb; 25(1 Pt 1):364-5. PubMed ID: 8438337
    [No Abstract]   [Full Text] [Related]  

  • 15. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of reexposure to mismatched major histocompatibility complex antigens on renal retransplant allograft survival.
    Farney AC; Noreen HJ; Sutherland DE; Reinsmoen N; Segall M; Gillingham K; Schmidt WJ; Matas AJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):213-4. PubMed ID: 8438275
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cold ischemia time and MHC class II matching in renal transplants.
    Iwaki Y; Cicciarelli J; Aswad S; Gavazov M; Obispo E; Khetan U; Bogaard T; Asai P; Mendez RG; Mendez R
    Transplant Proc; 1992 Dec; 24(6):2456-7. PubMed ID: 1465829
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular analysis of graft survival in renal transplantation by DNA typing of HLA class II antigens.
    Tsuji K; Inoko H; Ando A; Matsuno N; Ikewaki N; Sato T; Ichikawa Y; Sonoda T
    Transplant Proc; 1987 Feb; 19(1 Pt 1):662-3. PubMed ID: 3152706
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of tolerance to renal allografts across single-haplotype MHC disparities in miniature swine.
    Gianello PR; Lorf T; Yamada K; Fishbein JM; Nickeleit V; Vitiello DM; Sachs DH
    Transplantation; 1995 Mar; 59(6):884-90. PubMed ID: 7701585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.